Kawada Manabu, Yoshimoto Yuya, Minamiguchi Kazuhisa, Kumagai Hiroyuki, Someno Tetsuya, Masuda Tohru, Ishizuka Masaaki, Ikeda Daishiro
Drug Development Unit, Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center, Numazu-shi, Shizuoka 410-0301, Japan.
Anticancer Res. 2004 May-Jun;24(3a):1561-8.
Stromal cells play an important role in regulating epithelial malignancies through diffusible factors and adhesion. Modulation of the tumor-stromal cell interaction is an attractive target for new antitumor strategies. To screen for a modulator of the interaction, we have now developed a quantitative colorimetric assay for measurement of tumor cell growth in coculture with stromal cells using rhodanile blue dye. Rhodanile blue specifically stained cytokeratin-positive tumor cells in the coculture. When human prostate carcinoma cells LNCaP, PC-3 and DU-145 were cocultured with normal prostate stromal cells (PrSC) in a microplate, growth of the prostate cancer cells in the coculture was selectively measured by the rhodanile blue staining method. Using this system, we searched for a modulator of the tumor-stromal cell interaction among clinically used drugs and natural products. As a result, we found that 5-fluorouracil, bleomycin and phthoxazolin A inhibit prostate cancer cell growth more strongly in coculture with PrSC than that in monoculture. Without need to pre-label cells and transfect a marker gene, our new method is simple, rapid and thus useful for screening for modulators of the tumor-stromal cell interaction. Furthermore, our results suggest that low molecular weight compounds modulate the tumor-stromal cell interaction.
基质细胞通过可扩散因子和黏附作用在调节上皮性恶性肿瘤中发挥重要作用。肿瘤-基质细胞相互作用的调节是新抗肿瘤策略的一个有吸引力的靶点。为了筛选这种相互作用的调节剂,我们现在开发了一种定量比色测定法,使用罗丹宁蓝染料来测量与基质细胞共培养的肿瘤细胞生长。罗丹宁蓝能特异性地对共培养物中细胞角蛋白阳性的肿瘤细胞进行染色。当人前列腺癌细胞LNCaP、PC-3和DU-145与正常前列腺基质细胞(PrSC)在微孔板中共培养时,通过罗丹宁蓝染色法选择性地测量共培养物中前列腺癌细胞的生长。利用这个系统,我们在临床使用的药物和天然产物中寻找肿瘤-基质细胞相互作用的调节剂。结果,我们发现5-氟尿嘧啶、博来霉素和邻苯恶唑啉A在与PrSC共培养时比在单培养时更强烈地抑制前列腺癌细胞生长。我们的新方法无需预先标记细胞和转染标记基因,简单、快速,因此可用于筛选肿瘤-基质细胞相互作用的调节剂。此外,我们的结果表明低分子量化合物可调节肿瘤-基质细胞相互作用。